ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: A randomized phase 2 study

Paolo Strati, Michelle A. Fanale, Yasuhiro Oki, Francesco Turturro, Luis E. Fayad, Nancy L. Bartlett, Douglas E. Gladstone, Yvette L. Kasamon, Carol S. Portlock, Wyndham H. Wilson, Andre Goy, Anas Younes, Hun Ju Lee

Research output: Contribution to journalLetterpeer-review

7 Scopus citations
Original languageEnglish
Pages (from-to)e65-e67
JournalHaematologica
Volume104
Issue number2
DOIs
StatePublished - Jan 31 2019

Cite this